{"schema_version":"1","generated_at":"2026-11-04T03:41:49.298Z","data_as_of":null,"url":"https://www.findmykol.com/kol/meera-mohan","json_url":"https://www.findmykol.com/kol/meera-mohan/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"meera-mohan","name":"Meera Mohan","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1962718130","orcid":"0000-0002-6913-6526","openalex":"A5057629728"},"summary":"Meera Mohan is an Oncology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 194 publications with 1,761 citations (h-index 23); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":194,"cited_by_count":1761,"h_index":23,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07009899","title":"BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)","phase":"PHASE2","status":"NOT_YET_RECRUITING","role":"Overall official","sponsor":"Medical College of Wisconsin","source_url":"https://clinicaltrials.gov/study/NCT07009899","trial_url":"https://www.findmykol.com/trial/NCT07009899"},{"nct":"NCT05117008","title":"Maintenance Belantamab Mafodotin (Blenrep®) After B-cell Maturation Antigen-Directed Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed and/or Refractory Multiple Myeloma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Medical College of Wisconsin","source_url":"https://clinicaltrials.gov/study/NCT05117008","trial_url":"https://www.findmykol.com/trial/NCT05117008"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":36,"shown":3,"withheld":33,"rows":[{"payer":"Genzyme","program_year":2025,"amount_usd":2078609.27,"payment_count":13,"source_url":"https://openpaymentsdata.cms.gov/search?query=1962718130"},{"payer":"Bristol Myers Squibb","program_year":2025,"amount_usd":145634.9,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1962718130"},{"payer":"AbbVie","program_year":2025,"amount_usd":51175.35,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1962718130"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1962718130","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma","year":2025,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-025-01282-0","status":"verified"},{"title":"Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025016490","status":"verified"},{"title":"Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study","year":2025,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-025-01386-7","status":"verified"},{"title":"Real-world treatment patterns for teclistamab and talquetamab in multiple myeloma (MM): experience from 609 patients","year":2025,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-025-01254-4","status":"verified"},{"title":"Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study","year":2024,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-024-01003-z","status":"verified"}],"source":"works"},"contact":{"address_1":"1515 HOLCOMBE BLVD","city":"Houston","state":"TX","zip":"770304000","phone":"713-792-6161","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1962718130","source":"identity"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":33,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-04-14","provider_certified":"2026-04-14","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}